Did you know that Soligenix, is currently rushing to trial a ricin-rich vaccine RiVax® for #Marburg haemorrhagic fever? #RiVax has Fast Track designation for the prevention of ricin intoxication by the US FDA. Approval of ricin toxin vaccine will utilize the FDA Animal Rule to eliminate the phase 1, 2 & 3 trials. Why such a rush now, to trial a vaccine for which there has only been a total of 376 deaths since 1967 and only 16 deaths since 2005? The main component of the Rivax vaccine is #Ricin is a lectin and a highly potent toxin produced in the seeds of the castor oil plant.
Soligenix Investor Relations
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...